These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3914410)

  • 21. Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction.
    Gerber NL; Hardin JA; Chused TM; Steinberg AD
    J Immunol; 1974 Nov; 113(5):1618-25. PubMed ID: 4153571
    [No Abstract]   [Full Text] [Related]  

  • 22. Dominant role of Mlsa antigens in the induction of unresponsiveness to non-H-2 antigens.
    Berumen L; Pritchard LL; Goutner A; Halle-Pannenko O
    Transplant Proc; 1987 Feb; 19(1 Pt 1):506-7. PubMed ID: 3152703
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320
    [No Abstract]   [Full Text] [Related]  

  • 24. Host origin of follicular dendritic cells induced in the spleen of SCID mice after transfer of allogeneic lymphocytes.
    Yoshida K; Kaji M; Takahashi T; van den Berg TK; Dijkstra CD
    Immunology; 1995 Jan; 84(1):117-26. PubMed ID: 7890295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Increase of the GvH reaction after alloimmunization. Influence of the serologically defined determinants of the H-2 system].
    Brock J; Siegl E; Schulze HA
    Allerg Immunol (Leipz); 1982; 28(2):91-6. PubMed ID: 6182783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cell population dynamics with peroxidase in a regional graft vs. host reaction].
    Divanian Kh; Kovachev D; Tsanev D; Boshnakova E
    Eksp Med Morfol; 1987; 26(2):1-5. PubMed ID: 3608895
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 30. F1 hybrid resistance and self-tolerance in graft-versus-host mice.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1996 Oct; 28(5):2921-2. PubMed ID: 8908125
    [No Abstract]   [Full Text] [Related]  

  • 31. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Escherichia coli endotoxin on the graft-versus-host reaction in mice. 3. Runt disease in newborns.
    Skopińska E
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):305-8. PubMed ID: 4151942
    [No Abstract]   [Full Text] [Related]  

  • 33. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoid cell proliferation in non-lymphoid organs during graft-versus-host reactions (GVHR): I. Lack of correlation between mortality and grafted cell proliferation.
    Spach C; Motta R
    Exp Hematol; 1981 May; 9(5):531-9. PubMed ID: 7238660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic allotransplantation in the baboon. V. Preparation, characterization, and mode of action of a soluble donor spleen cell extract used to prolong graft survival.
    Smit JA; Robertson DJ; Myburgh JA
    Transplantation; 1972 Aug; 14(2):200-6. PubMed ID: 4403144
    [No Abstract]   [Full Text] [Related]  

  • 36. Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs.
    Abramowicz D; Durez P; Gerard C; Donckier V; Amraoui Z; Velu T; Goldman M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):312-3. PubMed ID: 8438314
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI).
    King DP; Srober S; Kaplan HS
    J Immunol; 1981 Mar; 126(3):1140-5. PubMed ID: 6450802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of endotoxin of Escherichia coli on the graft-versus-host reaction in mice. II. Non-H-2 systems.
    Skopińska E
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):301-4. PubMed ID: 4151941
    [No Abstract]   [Full Text] [Related]  

  • 39. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.